Charleston, SC -- (SBWIRE) -- 08/21/2013 -- ImpressivePennyStocks.com covers several stocks on the NASDAQ and New York Stock Exchange that technically qualify as penny stocks, we typically find ones that are on the OTC Market. ImpressivePennyStocks.com issues a special report on the following stocks: Janus Capital Group Inc(NYSE:JNS), Keryx Biopharmaceuticals(NASDAQ:KERX), Hemispherx BioPharma, Inc(NYSEMKT:HEB), Shanda Games Limited(ADR)(NASDAQ:GAME)
Janus Capital Group Inc(NYSE:JNS) ended its day with the gaining of +1.04% and closed at the price of $8.73 after opening at $8.65. Stock traded during its last trading session with the total volume of 2.08 million shares, as compared to its average volume of 2.51 million shares. Janus Capital Group Inc., and its subsidiaries (JCG) provide investment management, administration, distribution and related services to financial advisors, individuals and institutional clients through mutual funds, other pooled investment vehicles, separate accounts and sub advised relationships (collectively referred to as investment products) in both domestic and international markets.
Why Should Investors Buy JNS After The Recent Gain? Just Go Here and Find Out
Keryx Biopharmaceuticals(NASDAQ:KERX) stock traded during its last trading session with the total traded volume of 1.98 million shares, as compared to its average volume of 1.97 million shares. The company opened its shares at the price of $8.40 for the day and its closing price was $8.84 after gaining +5.11% for the day. Keryx Biopharmaceuticals, Inc. (Keryx) is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and renal disease.
For How Long KERX will fight for Profitability? Read This Trend Analysis report
Hemispherx BioPharma, Inc (NYSEMKT:HEB) traded with volume of 1.98 million shares in the last session, as compared to average volume of 634,404.00 shares. The company started its trading session with the price of $0.24 and closed at $0.24 by scoring +2.54%. Hemispherx Biopharma, Inc. (Hemispherx) is a specialty pharmaceutical company engaged in the clinical development of new drugs therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. The Company's foreign subsidiary is Hemispherx Biopharma Europe N.V./S.A.
Will HEB Continue To Move Higher? Find Out Here
Shanda Games Limited (ADR) (NASDAQ:GAME) ended its day with the loss of -2.79% and closed at the price of $4.53 after opening at $4.65. Stock traded during its last trading session with the total volume of 1.98 million shares, as compared to its average volume of 1.89 million shares. Shanda Games Limited (Shanda Games) is engaged in the development and operation of online games and related businesses in the People’s Republic of China. In April 2011, the Company acquired a 51.85% interest in a game operating company, which provides services in East Asia.
Will GAME Get Buyers Even After The Recent Rally? Find Out Here
About Impressive Penny Stocks:
We are different here at Impressive Penny Stocks because we care about our subscribers. You can email us any time with questions, tips, or just to say hello. We are real people and we love to hear from our loyal subscribers.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
Never invest into a stock discussed on this web site or the ImpressivePennyStocks.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
ImpressivePennyStocks.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. ImpressivePennyStocks’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by ImpressivePennyStocks or an offer or solicitation to buy or sell any security. Neither the owner of ImpressivePennyStocks nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. ImpressivePennyStocks makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors.
Read Full Disclaimer at: http://impressivepennystocks.com/disclaimer/#navigation
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)